{"abstract":"The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Blood Products Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. At least one portion of the meeting will be closed to the public.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/03/01/2017-03944.html","cfr_references":[],"citation":"82 FR 12229","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The meeting will be held on April 4, 2017, from 8:30 a.m. to 3:45 p.m. and on April 5, 2017, from 8:30 a.m. to 12 p.m.","disposition_notes":null,"docket_ids":["Docket No. FDA-2017-N-0001"],"dockets":[],"document_number":"2017-03944","effective_on":null,"end_page":12230,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/03/01/2017-03944.xml","html_url":"https://www.federalregister.gov/documents/2017/03/01/2017-03944/blood-products-advisory-committee-notice-of-meeting","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-03944?publication_date=2017-03-01","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-03-01/2017-03944/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":319,"last_updated":"2026-10-22 18:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-03-01/pdf/2017-03944.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-03944.pdf?1488289549","publication_date":"2017-03-01","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/03/01/2017-03944.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Weighing the Evidence Variant Classification & Interpretation in Precision - Transcript","document_id":"FDA-2017-N-0001-0049"}],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2017-N-0001","supporting_documents_count":1,"docket_id":"FDA-2017-N-0001","regulation_id_number":null,"title":"Advisory Committee, Workshops, and Conferences Notices Various Meeting Notices (e.g., Task Force Meeting, etc.)","checked_regulationsdotgov_at":"2017-03-21T06:00:20Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":12229,"subtype":null,"title":"Blood Products Advisory Committee; Notice of Meeting","toc_doc":"Blood Products Advisory Committee","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":82}